Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma
Clinical trial NCT00637832 · TERMINATED
Trial details
- NCT number
- NCT00637832
- Sponsor
- University of Southampton
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2015-01-06
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.